Cargando…
CureVac sues BioNTech over mRNA technology
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362402/ https://www.ncbi.nlm.nih.gov/pubmed/35945444 http://dx.doi.org/10.1038/s41587-022-01442-8 |
_version_ | 1784764717640712192 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9362402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93624022022-08-10 CureVac sues BioNTech over mRNA technology Nat Biotechnol News in Brief Nature Publishing Group US 2022-08-09 2022 /pmc/articles/PMC9362402/ /pubmed/35945444 http://dx.doi.org/10.1038/s41587-022-01442-8 Text en © Springer Nature America, Inc. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | News in Brief CureVac sues BioNTech over mRNA technology |
title | CureVac sues BioNTech over mRNA technology |
title_full | CureVac sues BioNTech over mRNA technology |
title_fullStr | CureVac sues BioNTech over mRNA technology |
title_full_unstemmed | CureVac sues BioNTech over mRNA technology |
title_short | CureVac sues BioNTech over mRNA technology |
title_sort | curevac sues biontech over mrna technology |
topic | News in Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362402/ https://www.ncbi.nlm.nih.gov/pubmed/35945444 http://dx.doi.org/10.1038/s41587-022-01442-8 |